United States Biotechnology & Medical Research

Biohaven Ltd (BHVN)

Track

Biohaven Ltd has experienced significant insider buying activity, with the most recent transactions occurring on November 17, 2025. Key executives and stakeholders, including the CEO and other insiders, executed multiple purchase orders throughout November 2025. These transactions represent a consistent pattern of accumulation by company leadership and major shareholders over the observed period.
Ticker: BHVN Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Biohaven Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 17 Nov 2025
Value US$3,633,208.24 | Price 247.46 | Shares 31,489 (-41.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-18 2025-11-17 B Purchase
3.2
Clark George C.

VP, Chief Accounting Officer

Officer
31,489 -41.5%
247.46
US$3,633,208 		31,489 -41.5% 247.46 US$3,633,208
2025-11-17 2025-11-13 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
58,989 +10.8%
436.82
US$1,449,735 		58,989 +10.8% 436.82 US$1,449,735
2025-11-17 2025-11-13 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
54,616 +0.3%
447.58
US$2,041,316 		54,616 +0.3% 447.58 US$2,041,316
2025-11-17 2025-11-13 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
3,333,333 +143.6%
7.50
US$24,999,998 		3,333,333 +143.6% 7.50 US$24,999,998
2025-11-17 2025-11-13 B Purchase
3.7
Bailey Gregory
Non-Executive Director
400,000 +24.7%
7.50
US$3,000,000 		400,000 +24.7% 7.50 US$3,000,000
2025-03-05 2025-03-04 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
900 +3.7%
30.73
US$27,653 		900 +3.7% 30.73 US$27,653
2025-03-05 2025-03-04 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
3,400 +4.6%
30.73
US$104,469 		3,400 +4.6% 30.73 US$104,469
2025-03-05 2025-03-04 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
3,400 +16.2%
30.73
US$104,469 		3,400 +16.2% 30.73 US$104,469
2025-03-05 2025-03-04 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
25,000 +1.1%
30.39
US$759,648 		25,000 +1.1% 30.39 US$759,648
2024-12-31 2024-12-30 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
29,000 +1.2%
35.94
US$1,042,393 		29,000 +1.2% 35.94 US$1,042,393
2024-10-03 2024-10-02 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
21,052 +2.5%
47.50
US$999,970 		21,052 +2.5% 47.50 US$999,970
2024-10-03 2024-10-02 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
21,052 +inf%
47.50
US$999,970 		21,052 +inf% 47.50 US$999,970
2024-09-25 2024-09-24 B Purchase
3.7
Bailey Gregory
Non-Executive Director
5,000 +0.3%
44.19
US$220,966 		5,000 +0.3% 44.19 US$220,966
2024-07-19 2024-07-18 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
28,400 +1.2%
35.67
US$1,012,983 		28,400 +1.2% 35.67 US$1,012,983
2024-06-20 2024-06-17 B Purchase
3.2
Car Bruce

Chief Scientific Officer

Officer
30,000 +inf%
33.58
US$1,007,490 		30,000 +inf% 33.58 US$1,007,490
2024-05-31 2024-05-30 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
28,000 +1.2%
35.58
US$996,240 		28,000 +1.2% 35.58 US$996,240
2024-05-15 2024-05-13 B Purchase
3.7
Bailey Gregory
Non-Executive Director
15,000 +0.9%
34.19
US$512,877 		15,000 +0.9% 34.19 US$512,877
2024-05-15 2024-05-13 B Purchase
3.7
Bailey Gregory
Non-Executive Director
15,000 +0.9%
34.19
US$512,877 		15,000 +0.9% 34.19 US$512,877
2024-05-14 2024-05-13 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
28,500 +1.3%
35.17
US$1,002,470 		28,500 +1.3% 35.17 US$1,002,470
2024-04-25 2024-04-24 B Purchase
3.7
Bailey Gregory
Non-Executive Director
25,503 +1.6%
39.18
US$999,169 		25,503 +1.6% 39.18 US$999,169
2024-04-23 2024-04-22 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
73,170 +3.4%
41.00
US$2,999,970 		73,170 +3.4% 41.00 US$2,999,970
2024-04-23 2024-04-22 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
97,560 +2.4%
41.00
US$3,999,960 		97,560 +2.4% 41.00 US$3,999,960
2024-04-23 2024-04-22 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
24,391 +inf%
41.00
US$1,000,031 		24,391 +inf% 41.00 US$1,000,031
2024-04-23 2024-04-22 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
121,951 +7.3%
41.00
US$4,999,991 		121,951 +7.3% 41.00 US$4,999,991
2024-04-23 2024-04-22 B Purchase
3.7
Bailey Gregory
Non-Executive Director
48,780 +3.2%
41.00
US$1,999,980 		48,780 +3.2% 41.00 US$1,999,980
2023-12-29 2023-12-29 PrS Proposed sale
1.3
Antonijevic Irina

Director

Non-Executive Director
11,000
41.79
US$459,663 		11,000 41.79 US$459,663
2023-12-29 2023-12-29 S Sale
1.3
Antonijevic Irina
Non-Executive Director
11,000 -81.3%
41.79
US$459,662 		11,000 -81.3% 41.79 US$459,662
2023-10-10 2023-10-05 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
113,637 +7.4%
22.00
US$2,500,014 		113,637 +7.4% 22.00 US$2,500,014
2023-10-10 2023-10-05 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
340,908 +69.3%
22.00
US$7,499,976 		340,908 +69.3% 22.00 US$7,499,976
2023-10-10 2023-10-05 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
136,545 +6.9%
22.00
US$3,003,990 		136,545 +6.9% 22.00 US$3,003,990
2023-10-10 2023-10-05 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
318,000 +8.6%
22.00
US$6,996,000 		318,000 +8.6% 22.00 US$6,996,000
2023-10-06 2023-10-05 B Purchase
3.4
Buten Matthew

Chief Financial Officer

Officer
22,727 +13.6%
22.00
US$499,994 		22,727 +13.6% 22.00 US$499,994
2023-10-06 2023-10-04 B Purchase
3.7
Bailey Gregory
Non-Executive Director
17,817 +1.2%
22.57
US$402,094 		17,817 +1.2% 22.57 US$402,094
2023-08-31 2023-08-30 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
50,000 +2.6%
18.44
US$922,180 		50,000 +2.6% 18.44 US$922,180
2023-08-07 2023-08-04 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
100,000 +5.5%
19.78
US$1,978,430 		100,000 +5.5% 19.78 US$1,978,430
2022-11-01 2022-10-31 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
25,800 +1.7%
15.97
US$411,995 		25,800 +1.7% 15.97 US$411,995
2022-10-31 2022-10-28 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
100,000 +1045.5%
14.82
US$1,482,420 		100,000 +1045.5% 14.82 US$1,482,420
2022-10-31 2022-10-28 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
41,930 +2.8%
14.87
US$623,352 		41,930 +2.8% 14.87 US$623,352
2022-10-26 2022-10-25 B Purchase
3.7
Bailey Gregory
Non-Executive Director
200,000 +15.3%
10.50
US$2,100,000 		200,000 +15.3% 10.50 US$2,100,000
2022-10-26 2022-10-25 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
853,380 +137.1%
10.50
US$8,960,490 		853,380 +137.1% 10.50 US$8,960,490
2022-10-26 2022-10-25 B Purchase
3.4
Buten Matthew

Chief Financial Officer

Officer
142,857 +600.3%
10.50
US$1,499,998 		142,857 +600.3% 10.50 US$1,499,998
2022-10-26 2022-10-25 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
3,900,000 +217.7%
10.50
US$40,950,000 		3,900,000 +217.7% 10.50 US$40,950,000
2022-10-26 2022-10-25 B Purchase
2.4
GREGORY JULIA P
Non-Executive Director
9,523 +59.0%
10.50
US$99,992 		9,523 +59.0% 10.50 US$99,992
2022-10-06 2022-10-05 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
2,100 +0.5%
12.35
US$25,928 		2,100 +0.5% 12.35 US$25,928
2022-10-06 2022-10-05 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
52,523 +15.2%
11.79
US$619,162 		52,523 +15.2% 11.79 US$619,162
2022-10-06 2022-10-05 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
80,606 +30.5%
10.82
US$871,907 		80,606 +30.5% 10.82 US$871,907
2022-10-06 2022-10-05 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
34,459 +15.0%
9.89
US$340,968 		34,459 +15.0% 9.89 US$340,968
2022-10-06 2022-10-05 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
73,005 +46.6%
8.82
US$644,130 		73,005 +46.6% 8.82 US$644,130
2022-10-06 2022-10-05 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
54,329 +12.4%
11.83
US$642,614 		54,329 +12.4% 11.83 US$642,614
2022-10-06 2022-10-05 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
80,907 +22.7%
10.83
US$875,843 		80,907 +22.7% 10.83 US$875,843
2022-10-06 2022-10-05 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
34,515 +10.7%
9.90
US$341,843 		34,515 +10.7% 9.90 US$341,843
2022-10-06 2022-10-05 B Purchase
4.1
Coric Vlad

Chief Executive Officer

Executive Director
73,331 +29.4%
8.82
US$647,029 		73,331 +29.4% 8.82 US$647,029
2022-10-05 2022-10-05 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
32,841 +1.9%
9.70
US$318,403 		32,841 +1.9% 9.70 US$318,403
2022-10-05 2022-10-05 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
241,300 +15.9%
8.88
US$2,142,768 		241,300 +15.9% 8.88 US$2,142,768
Explore more

More insider trading research around Biohaven Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America